col0,col1
"Safety, Immunogenicity and Dose Ranging""Study of Inactivated Zika Virus Vaccine in Healthy Adult Participants",239.52
Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic inthe French West Indies in a Sample of Patients Followed for HIV Infection.,364.172
ZIKAlliance Pregnant Women Chort,4975.0
"Safety, Tolerability, an Immunogenicity of mRNA-1325 in Healthy Adult Subjects",90.0
ZIKAlliance Childrgn Cohort (ZIKAllianceCH),5020.0
